Summary
IDEXX Laboratories, Inc. (IDXX) filed an 8-K on March 11, 2014, to report the election of Daniel M. Junius as an independent director to its Board of Directors. Mr. Junius will serve on the audit committee and his term is expected to end at the 2015 annual meeting, with a potential three-year term expiring in 2018. This appointment addresses a vacancy within Class I of the Board. Mr. Junius's compensation will align with that of other non-employee directors, including prorated cash fees for the current quarter and annual stock unit and stock option grants. The company also furnished a press release related to this appointment as an exhibit to the filing. This filing does not contain significant financial updates but focuses on corporate governance.
Key Highlights
- 1IDEXX Laboratories appointed Daniel M. Junius as a new independent director on March 11, 2014.
- 2Mr. Junius has been appointed as a member of the company's audit committee.
- 3His election fills a vacancy in Class I of the Board of Directors.
- 4Mr. Junius's term is expected to run until the 2015 annual meeting, with a potential re-election for a three-year term ending in 2018.
- 5Non-employee director compensation, including stock grants, will be provided to Mr. Junius.
- 6A press release announcing Mr. Junius's appointment is included as an exhibit.